Cancer Causes & Control

, Volume 24, Issue 7, pp 1323–1330

Relationship between cancer survival and ambient ultraviolet B irradiance in China

  • Wanqing Chen
  • Bruce K. Armstrong
  • Bayzidur Rahman
  • Rongshou Zheng
  • Siwei Zhang
  • Mark Clements
Original paper

Abstract

Background

Ecological studies in predominantly European populations have reported higher cancer survival in areas of higher solar ultraviolet (UV) B irradiation, perhaps due to a cancer protective effect of vitamin D synthesized photochemically in the skin. Such studies have not been done in developing countries, perhaps because of lack of cancer registries that can do outcome follow-up. One minus the mortality-to-incidence ratio (1−MIR), however, can be used as a measure of survival, and MIR as a measure of fatality, in developing country cancer registries. We analyzed the association between ambient solar UVB and MIR in China.

Methods

National cancer registration data in 32 counties of China in 2004–2005 were used to estimate MIR by age, sex, and area. The accuracy of 1−MIR as a measure of survival was assessed in the Cixian County cancer registry. Contemporary satellite measurements of cloud-adjusted ambient UVB intensity at 305 nm were taken from an NASA database and spatial Kriging methods used to estimate the average daily irradiance in each county. We estimated mortality hazard ratios (HRs) per 10 mW/m2 of UVB for all cancers together, and the ten commonest cancer types by fitting a generalized linear model assuming mortality had a binomial distribution conditional on the sum of mortality and incidence, adjusted for sex, age, and location.

Results

The 5-year survival proportions for the main cancer types were in good agreement with 1−MIR in Cixian County. MIR ratios for all cancers combined were inversely associated with ambient UVB in men (HR = 0.96, 95 % CI 0.93–0.99) and women (HR = 0.91, 95 % CI 0.88–0.94) and in urban (HR = 0.95, 95 % CI 0.94–0.96) and rural areas (HR = 0.90, 95 % CI 0.87–0.93). Similar inverse associations were present for cancers of esophagus, stomach, and bladder in both sexes together and breast cancer in women. They were present in urban residents for all major cancers except liver cancer, bladder cancer, and breast cancer in women. For rural residents, most HRs were <1.0 but, with the exception of breast cancer, their upper 95 % confidence bounds were >1.0.

Conclusion

Ambient UVB was significantly inversely associated with MIR for all cancers together and four of ten cancer types. Solar UVB may increase survival from some cancers in China.

Keywords

Cancer Mortality Incidence Survival UVB Generalized linear model China 

References

  1. 1.
    Grant WB, Juzeniene A, Lagunova Z et al (2011) Vitamin D levels in Norway may be inadequate to reduce risk of breast cancer. Int J Cancer 128(9):2249–2250PubMedCrossRefGoogle Scholar
  2. 2.
    Porojnicu AC, Robsahm TE, Dahlback A et al (2007) Seasonal and geographical variations in lung cancer prognosis in Norway. Does Vitamin D from the sun play a role? Lung Cancer 55(3):263–270PubMedCrossRefGoogle Scholar
  3. 3.
    Moan J, Porojnicu AC, Robsahm TE et al (2005) Solar radiation, vitamin D and survival rate of colon cancer in Norway. J Photochem Photobiol, B 78(3):189–193CrossRefGoogle Scholar
  4. 4.
    Robsahm TE, Tretli S, Dahlback A et al (2004) Vitamin D3 from sunlight may improve the prognosis of breast-, colon- and prostate cancer (Norway). Cancer Causes Control 15(2):149–158PubMedCrossRefGoogle Scholar
  5. 5.
    Porojnicu A, Robsahm TE, Berg JP et al (2007) Season of diagnosis is a predictor of cancer survival. Sun-induced vitamin D may be involved: a possible role of sun-induced Vitamin D. J Steroid Biochem Mol Biol 103(3–5):675–678PubMedCrossRefGoogle Scholar
  6. 6.
    Zhou W, Suk R, Liu G et al (2005) Vitamin D is associated with improved survival in early-stage non-small cell lung cancer patients. Cancer Epidemiol Biomarkers Prev 14(10):2303–2309PubMedCrossRefGoogle Scholar
  7. 7.
    Holmberg L, Adolfsson J, Mucci L et al (2009) Season of diagnosis and prognosis in breast and prostate cancer. Cancer Causes Control 20(5):663–670PubMedCrossRefGoogle Scholar
  8. 8.
    Roychoudhuri R, Robinson D, Coupland V et al (2009) Season of cancer diagnosis exerts distinct effects upon short- and long-term survival. Int J Cancer 124(10):2436–2441PubMedCrossRefGoogle Scholar
  9. 9.
    Teilum D, Bjerre KD, Tjonneland AM et al (2012) Breast cancer survival and season of surgery: an ecological open cohort study. BMJ Open 2:e000358PubMedCrossRefGoogle Scholar
  10. 10.
    Chen W, Clements M, Rahman B et al (2010) Relationship between cancer mortality/incidence and ambient ultraviolet B irradiance in China. Cancer Causes Control 21(10):1701–1709PubMedCrossRefGoogle Scholar
  11. 11.
    Asadzadeh Vostakolaei F, Karim-Kos HE, Janssen-Heijnen ML et al (2011) The validity of the mortality to incidence ratio as a proxy for site-specific cancer survival. Eur J Public Health 21(5):573–577PubMedCrossRefGoogle Scholar
  12. 12.
    National Central Cancer Registry (2008) Disease prevention and control bureau ministry of health: 2004 chinese cancer registry annual report. Union Medical College press, BeijingGoogle Scholar
  13. 13.
    Li GL, Chen WQ (2010) Representativeness of population-based cancer registration in China—comparison of urban and rural areas. Asian Pac J Cancer Prev 10:559–564Google Scholar
  14. 14.
    Li GL, Chen WQ (2009) Representativeness of population-based cancer registration in China—comparison of urban and rural areas. Asian Pac J Cancer Prev 10(4):559–564PubMedGoogle Scholar
  15. 15.
  16. 16.
    Herman JR, Krotkov N, Celarier E et al (1999) Distribution of UV radiation at the Earth’s surface from TOMS-measured UV-backscattered radiances. J Geophys Res Atmos 104(D10):12059–12076CrossRefGoogle Scholar
  17. 17.
    Bjorn LO (2010) Vitamin D synthesis may be independent of skin pigmentation only with UV of short wavelength. J Invest Dermatol 130(12):2848–2850PubMedCrossRefGoogle Scholar
  18. 18.
    Ederer F, Heise H: Instructions to IBM 650 programmers in processing survival computations. Methodological note No. 10, End Results section National Cancer Institute, Bethesda, MD (1959)Google Scholar
  19. 19.
    Ferlay J, Shin HR, Bray F et al (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127(12):2893–2917PubMedCrossRefGoogle Scholar
  20. 20.
    Grant WB (2007) Does solar ultraviolet irradiation affect cancer mortality rates in China? Asian Pac J Cancer Prev 8(2):236–242PubMedGoogle Scholar
  21. 21.
    Archer VE (1989) Latitudinal variation of digestive tract cancers in the US and China. Nutr Cancer 12(3):213–223PubMedCrossRefGoogle Scholar
  22. 22.
    Parkin DM, Bray F (2009) Evaluation of data quality in the cancer registry: principles and methods Part II. Completeness. Eur J Cancer 45(5):756–764PubMedCrossRefGoogle Scholar
  23. 23.
    Valean S, Armean P, Resteman S et al (2008) Cancer mortality in Romania, 1955–2004. Digestive sites: esophagus, stomach, colon and rectum, pancreas, liver, gallbladder and biliary tree. J Gastrointestin Liver Dis 17(1):9–14PubMedGoogle Scholar
  24. 24.
    Pisani P, Parkin DM, Ferlay J (1993) Estimates of the worldwide mortality from eighteen major cancers in 1985. Implications for prevention and projections of future burden. Int J Cancer 55(6):891–903PubMedCrossRefGoogle Scholar
  25. 25.
    Hebert JR, Daguise VG, Hurley DM et al (2009) Mapping cancer mortality-to-incidence ratios to illustrate racial and sex disparities in a high-risk population. Cancer 115(11):2539–2552PubMedCrossRefGoogle Scholar
  26. 26.
    Porojnicu AC, Lagunova Z, Robsahm TE et al (2007) Changes in risk of death from breast cancer with season and latitude: sun exposure and breast cancer survival in Norway. Breast Cancer Res Treat 102(3):323–328PubMedCrossRefGoogle Scholar
  27. 27.
    Lim HS, Roychoudhuri R, Peto J et al (2006) Cancer survival is dependent on season of diagnosis and sunlight exposure. Int J Cancer 119(7):1530–1536PubMedCrossRefGoogle Scholar
  28. 28.
    Boniol M, Armstrong BK, Dore JF (2006) Variation in incidence and fatality of melanoma by season of diagnosis in new South Wales. Australia. Cancer Epidemiol Biomarkers Prev 15(3):524–526PubMedCrossRefGoogle Scholar
  29. 29.
    Porojnicu AC, Robsahm TE, Ree AH et al (2005) Season of diagnosis is a prognostic factor in Hodgkin’s lymphoma: a possible role of sun-induced vitamin D. Br J Cancer 93(5):571–574PubMedCrossRefGoogle Scholar
  30. 30.
    Grant WB (2012) Ecological studies of the UVB-vitamin D-cancer hypothesis. Anticancer Res 32(1):223–236PubMedGoogle Scholar
  31. 31.
    Turna A, Pekcolaklar A, Metin M et al (2012) The effect of season of operation on the survival of patients with resected non-small cell lung cancer. Interact Cardiovasc Thorac Surg 14(2):151–155PubMedCrossRefGoogle Scholar
  32. 32.
    Hakko H, Rasanen P, Niemela A et al (2009) Season of tumor surgery in relation to deaths among brain tumor patients: does sunlight and month of surgery play a role in brain tumor deaths? Acta Neurochir (Wien) 151(11):1369–1375CrossRefGoogle Scholar
  33. 33.
    Jayasekara H, Karahalios E, Thursfield V et al (2009) Season of diagnosis has no effect on survival from malignant melanoma. Int J Cancer 125(2):488–490PubMedCrossRefGoogle Scholar
  34. 34.
    Zhou W, Heist RS, Liu G et al (2007) Circulating 25-hydroxyvitamin D levels predict survival in early-stage non-small-cell lung cancer patients. J Clin Oncol 25(5):479–485PubMedCrossRefGoogle Scholar
  35. 35.
    Newton-Bishop JA, Beswick S, Randerson-Moor J et al (2009) Serum 25-hydroxyvitamin D3 levels are associated with breslow thickness at presentation and survival from melanoma. J Clin Oncol 27(32):5439–5444PubMedCrossRefGoogle Scholar
  36. 36.
    Ng K, Wolpin BM, Meyerhardt JA et al (2009) Prospective study of predictors of vitamin D status and survival in patients with colorectal cancer. Br J Cancer 101(6):916–923PubMedCrossRefGoogle Scholar
  37. 37.
    Tretli S, Hernes E, Berg JP et al (2009) Association between serum 25(OH)D and death from prostate cancer. Br J Cancer 100(3):450–454PubMedCrossRefGoogle Scholar
  38. 38.
    Goodwin PJ, Ennis M, Pritchard KI et al (2009) Prognostic effects of 25-hydroxyvitamin D levels in early breast cancer. J Clin Oncol 27(23):3757–3763PubMedCrossRefGoogle Scholar
  39. 39.
    Mezawa H, Sugiura T, Watanabe M et al (2010) Serum vitamin D levels and survival of patients with colorectal cancer: post hoc analysis of a prospective cohort study. BMC Cancer 10:347PubMedCrossRefGoogle Scholar
  40. 40.
    Vrieling A, Hein R, Abbas S et al (2011) Serum 25-hydroxyvitamin D and postmenopausal breast cancer survival: a prospective patient cohort study. Breast Cancer Res 13(4):R74PubMedCrossRefGoogle Scholar
  41. 41.
    Fedirko V, Riboli E, Tjonneland A et al (2012) Prediagnostic 25-hydroxyvitamin D, VDR and CASR polymorphisms, and survival in patients with colorectal cancer in western European populations. Cancer Epidemiol Biomarkers Prev 21(4):582–593PubMedCrossRefGoogle Scholar
  42. 42.
    Tretli S, Schwartz GG, Torjesen PA et al (2012) Serum levels of 25-hydroxyvitamin D and survival in Norwegian patients with cancer of breast, colon, lung, and lymphoma: a population-based study. Cancer Causes Control 23(2):363–370PubMedCrossRefGoogle Scholar
  43. 43.
    Drake MT, Maurer MJ, Link BK et al (2010) Vitamin D insufficiency and prognosis in non-Hodgkin’s lymphoma. J Clin Oncol 28(27):4191–4198PubMedCrossRefGoogle Scholar
  44. 44.
    Thomas X, Chelghoum Y, Fanari N et al (2011) Serum 25-hydroxyvitamin D levels are associated with prognosis in hematological malignancies. Hematology 16(5):278–283PubMedCrossRefGoogle Scholar
  45. 45.
    Heist RS, Zhou W, Wang Z et al (2008) Circulating 25-hydroxyvitamin D, VDR polymorphisms, and survival in advanced non-small-cell lung cancer. J Clin Oncol 26(34):5596–5602PubMedCrossRefGoogle Scholar
  46. 46.
    Jacobs ET, Thomson CA, Flatt SW et al (2011) Vitamin D and breast cancer recurrence in the Women’s Healthy Eating and Living (WHEL) Study. Am J Clin Nutr 93(1):108–117PubMedCrossRefGoogle Scholar
  47. 47.
    Meyer F, Liu G, Douville P et al (2011) Dietary vitamin D intake and serum 25-hydroxyvitamin D level in relation to disease outcomes in head and neck cancer patients. Int J Cancer 128(7):1741–1746PubMedCrossRefGoogle Scholar
  48. 48.
    Wee JT, Ha TC, Loong SL et al (2010) Is nasopharyngeal cancer really a “Cantonese cancer”? Chin J Cancer 29(5):517–526PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media Dordrecht 2013

Authors and Affiliations

  • Wanqing Chen
    • 1
    • 2
  • Bruce K. Armstrong
    • 2
  • Bayzidur Rahman
    • 3
  • Rongshou Zheng
    • 1
  • Siwei Zhang
    • 1
  • Mark Clements
    • 4
    • 5
  1. 1.Cancer Institute, Chinese Academy of Medical SciencesBeijingChina
  2. 2.School of Public HealthThe University of SydneySydneyAustralia
  3. 3.School of Public HealthUniversity of New South WalesKensingtonAustralia
  4. 4.National Centre for Epidemiology and Population HealthAustralian National UniversityCanberraAustralia
  5. 5.Department of Medical Epidemiology and BiostatisticsKarolinska InstitutetStockholmSweden

Personalised recommendations